CUSP Uro-Oncology Network

CUSP Uro-Oncology Network, officially known as the Consortium for Urologic Strategic Partnerships, is a premier clinical research organization comprised of large, independent urology group practices across the United States. The network specializes in the execution of Phase 1 through Phase 4 clinical trials, focusing specifically on urologic malignancies such as prostate, bladder, and renal cancers. By aggregating the clinical resources and patient populations of its member practices, CUSP provides pharmaceutical and biotechnology sponsors with a streamlined, high-volume platform for drug development. The organization utilizes a centralized infrastructure to ensure standardized data collection, rapid patient recruitment, and adherence to rigorous regulatory requirements. CUSP's collaborative model allows community-based urologists to participate in cutting-edge research, bringing innovative therapies directly to their patient populations.